logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Joseph Brandwein

university of alberta
H指数:52
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis

CPX-351治疗继发性急性髓系白血病的真实世界经验：与FLAG-IDA的倾向性评分匹配分析

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-12-010
OAAI
Perusini, Maria Agustina; Patino, Ana Flavia; Andrews, Claire; Assouline, Sarit E.; Brandwein, Joseph M.; Chow, Signy; Popradi, Gizelle; Sanford, David; Savoie, Lynn; Saini, Lalit; Nadia, Bambace; Khalaf, Dina; Schuh, Andre C.; Yee, Karen; Gupta, Vikas; Maze, Dawn; Chan, Steven M.; Schimmer, Aaron D.; Sabry, Waleed; Sibai, Hassan
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial

enasidenib联合venetoclax在IDH2突变型复发或难治性急性髓系白血病或骨髓增生异常综合征患者中的疗效研究（ENAVEN-AML）：一项多中心、单臂、1b/2期临床试验

The Lancet Haematology
IF0
2025-10-080
PRE
Guillaume Richard-Carpentier; Gopila Gupta; Charina Koraksic; Severine Cathelin; Lisa Wang; Aniket Bankar; Marta Davidson; Vikas Gupta; Dawn Maze; Mark D Minden; Tracy Murphy; Aaron D Schimmer; Andre C Schuh; Hassan Sibai; Karen Yee; Courtney D DiNardo; Joseph Brandwein; Caroline J McNamara; Steven M Chan
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation
BMC CANCER
IF3.4
2025-01-280
OAAI
Pituskin, Edith; Foulkes, Stephen; Skow, Rachel J.; Mcmurtry, Thomas; Kruger, Calvin; Bates, Janet E.; Lamoureux, Daena; Brandwein, Joseph; Lieuw, Elena; Wu, Cynthia; Zhu, Nancy; Wang, Peng; Sawler, Daniel; Taparia, Minakshi; Hamilton, Marlene; Comfort-Riddle, Tiffany; Meyer, Tara; Gyenes, Gabor T.; Paterson, Ian; Prado, Carla M.; Haykowsky, Mark J.; Greiner, Justin G.; Mcneely, Margaret L.; Tandon, Puneeta; Thompson, Richard B.
10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years

10年随访研究：CALGB 10603/Ratify试验中，年龄18-60岁新诊断FLT3突变急性髓系白血病患者的米哚妥林与安慰剂联合强化化疗的比较

BLOOD
IF23.1
2024-11-050
PRE
Stone, Richard M.; Yin, Jun; Mandrekar, Sumithra J.; Benner, Axel; Saadati, Maral; Galinsky, Ilene A.; Sanford, Ben L.; Teske, Rebecca; Geyer, Susan M.; Prior, Thomas; Amadori, Sergio; Appelbaum, Frederick R.; Brandwein, Joseph; Dohner, Konstanze; Ehninger, Gerhard; Ganser, Arnold; Klisovic, Rebecca B.; Krauter, Jurgen; Marcucci, Guido; Medeiros, Bruno; Niederwieser, Dietger W.; Sanz, Miguel A.; Schlenk, Richard F.; Serve, Hubert; Sierra, Jorge; Tallman, Martin S.; Wei, Andrew H.; Witte, Theo J. M. de; Thiede, Christian; Doehner, Hartmut; Larson, Richard A.
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
BLOOD ADVANCES
IF7.1
2023-08-286
OAAI
Fenaux, Pierre; Gobbi, Marco; Kropf, Patricia L.; Issa, Jean-Pierre J.; Roboz, Gail J.; Mayer, Jiri; Krauter, Juergen; Robak, Tadeusz; Kantarjian, Hagop; Novak, Jan; Jedrzejczak, Wieslaw. W.; Thomas, Xavier; Ojeda-Uribe, Mario; Miyazaki, Yasushi; Min, Yoo Hong; Yeh, Su-Peng; Brandwein, Joseph; Gercheva-Kyuchukova, Liana; Demeter, Judit; Griffiths, Elizabeth; Yee, Karen; Doehner, Konstanze; Hao, Yong; Keer, Harold; Azab, Mohammad; Doehner, Hartmut
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

在CALGB 10603/批准试验中治疗的FLT3-mutated急性髓系白血病 (AML) 患者的基因组景观

LEUKEMIA
IF13.4
2022-08-0325
OAAI
Jahn, Nikolaus; Jahn, Ekaterina; Saadati, Maral; Bullinger, Lars; Larson, Richard A.; Ottone, Tiziana; Amadori, Sergio; Prior, Thomas W.; Brandwein, Joseph M.; Appelbaum, Frederick R.; Medeiros, Bruno C.; Tallman, Martin S.; Ehninger, Gerhard; Heuser, Michael; Ganser, Arnold; Pallaud, Celine; Gathmann, Insa; Krzykalla, Julia; Benner, Axel; Bloomfield, Clara D.; Thiede, Christian; Stone, Richard M.; Doehner, Hartmut; Doehner, Konstanze
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

急性髓系白血病中FLT3-ITD插入位点的分子景观和预后影响: 批准研究结果

LEUKEMIA
IF13.4
2021-07-2852
OAAI
Rucker, Frank G.; Du, Ling; Luck, Tamara J.; Benner, Axel; Krzykalla, Julia; Gathmann, Insa; Voso, Maria Teresa; Amadori, Sergio; Prior, Thomas W.; Brandwein, Joseph M.; Appelbaum, Frederick R.; Medeiros, Bruno C.; Tallman, Martin S.; Savoie, Lynn; Sierra, Jorge; Pallaud, Celine; Sanz, Miguel A.; Jansen, Joop H.; Niederwieser, Dietger; Fischer, Thomas; Ehninger, Gerhard; Heuser, Michael; Ganser, Arnold; Bullinger, Lars; Larson, Richard A.; Bloomfield, Clara D.; Stone, Richard M.; Doehner, Hartmut; Thiede, Christian; Doehner, Konstanze
Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia

扩增的抗原经历的CD160 CD8效应T细胞在慢性淋巴细胞白血病中表现出受损的效应子功能

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2021-04-3032
OAAI
Bozorgmehr, Najmeh; Okoye, Isobel; Oyegbami, Olaide; Xu, Lai; Fontaine, Amelie; Cox-Kennett, Nanette; Larratt, Loree M.; Hnatiuk, Mark; Fagarasanu, Andrei; Brandwein, Joseph; Peters, Anthea C.; Elahi, Shokrollah
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
LEUKEMIA
IF13.4
2021-03-0259
OA
Larson, Richard A.; Mandrekar, Sumithra J.; Huebner, Lucas J.; Sanford, Ben L.; Laumann, Kristina; Geyer, Susan; Bloomfield, Clara D.; Thiede, Christian; Prior, Thomas W.; Dohner, Konstanze; Marcucci, Guido; Voso, Maria Teresa; Klisovic, Rebecca B.; Galinsky, Ilene; Wei, Andrew H.; Sierra, Jorge; Sanz, Miguel A.; Brandwein, Joseph M.; de Witte, Theo; Niederwieser, Dietger; Appelbaum, Frederick R.; Medeiros, Bruno C.; Tallman, Martin S.; Krauter, Jurgen; Schlenk, Richard F.; Ganser, Arnold; Serve, Hubert; Ehninger, Gerhard; Amadori, Sergio; Gathmann, Insa; Dohner, Hartmut; Stone, Richard M.
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Midostaurin在急性髓性白血病和FLT3-TKD突变患者中的应用: 来自批准试验的子分析

BLOOD ADVANCES
IF7.1
2020-10-1337
OAAI
Voso, Maria Teresa; Larson, Richard A.; Jones, Dan; Marcucci, Guido; Prior, Thomas; Krauter, Jurgen; Heuser, Michael; Lavorgna, Serena; Nomdedeu, Josep; Geyer, Susan M.; Walker, Alison; Wei, Andrew H.; Sierra, Jorge; Sanz, Miguel A.; Brandwein, Joseph M.; de Witte, Theo M.; Jansen, Joop H.; Niederwieser, Dietger; Appelbaum, Frederick R.; Medeiros, Bruno C.; Tallman, Martin S.; Schlenk, Richard F.; Ganser, Arnold; Amadori, Sergio; Cheng, Yuan; Chen, YinMiao; Pallaud, Celine; Du, Ling; Piciocchi, Alfonso; Ehninger, Gerhard; Byrd, John; Thiede, Christian; Dohner, Konstanze; Stone, Richard M.; Dohner, Hartmut; Bloomfield, Clara D.; Lo-Coco, Francesco

研究方向

暂未获取到该数据
M
Mark D. Minden
H 指数:92论文数:1,259被引数:4.4万
A
Andre C. Schuh
H 指数:46论文数:368被引数:1.7万
K
Karen Yee
H 指数:45论文数:392被引数:1.0万
A
Aaron D. Schimmer
H 指数:0论文数:5被引数:0
V
Vikas Gupta
H 指数:75论文数:896被引数:2.4万
S
Shabbir M.H. Alibhai
H 指数:67论文数:726被引数:1.7万
G
George Tomlinson
H 指数:107论文数:865被引数:4.8万
R
Richard A. Larson
H 指数:147论文数:1,507被引数:11.6万
H
Hartmut Döhner
H 指数:146论文数:1,384被引数:11.3万
R
Richard M. Stone
H 指数:132论文数:1,855被引数:7.5万